Struggle to Live-The Fight Against TB
Photographs by James Nachtwey Opens January 20, 2010
James Nachtwey has documented the resurgence of tuberculosis and its varying strains MDR and XDR in seven countries around the world. These countries include Cambodia, Lesotho, South Africa, Siberia, India, Swaziland, and Thailand. He has captured the lives of both patients and health care workers in the struggle against this ancient disease, which still remains very much a part of the present. Not only does TB remain a killer disease in its most recognizable form but it is mutating into even more deadly forms: multi-drug resistant (MDR) and extremely drug resistant (XDR) TB. While still a small subset of the TB cases, these new strains pose a grave global health threat. XDR-TB is a man-made catastrophe, resulting from too little resources being allocated for the proper diagnosis and treatment of TB patients in developing countries.
"Despite the fact that tuberculosis afflicts a huge number of people it's not on the radar screen in terms of public awareness. Normal tuberculosis, if treated diligently, is very inexpensive and doesn¹t take very long to cure. But if normal TB is not treated, it mutates and becomes 100 times more expensive, requires a two-year cure and a long stay in the hospital, which many of those infected cannot afford. The thought of XDR getting out of control is truly frightening," says James Nachtwey.
This exhibition was made possible with the help of BD.
The rapid and accurate diagnosis of symptomatic patients is the cornerstone of global strategies for TB control. BD (Becton, Dickinson and Company) is committed to increasing access to improved TB diagnostics worldwide. BD focuses not only on ensuring access to its existing TB diagnostic technologies, but also is investing in much-needed improved TB diagnostics.
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com
Cambodian Health Committee - www.cambodianhealthcommittee.org